Share Success: Letters From Readers
I: From Linda
Submit Form on Wednesday, January 01, 2014 at 09:47:34
Hi, my name is Linda, and I gave eZorb to a friend who was limping. She loves it, says it really helped her.
I have been taking it for years for my osteoporosis, and I never have any aches or pains. The best part is, I started giving one teaspoon a day of the powder to my 15 year old failing Chihuahua (mixed in his soft food), and he is feeling much better! It has really made a difference in his mobility.
II: From John B.
at Distributor Email on Sunday, August 12, 2013 at 00:00:05
I have been working in the construction industry for over 30 years. Also I have been a professional Armwrestler for over 20 years and I am still competing. In fact I am the current national champion at 198 lbs in the over 60 class.
I have suffered many injuries during my Armwrestling career. One injury the doctor told me that the only way to fix the problem was with surgery. The problem was I had bone spurs that was extremely painful and I thought there must be a natural way to cure my problem.
I research the internet and found your product EZorb and started taking the supplement. With in 4 months I was cured it's amazing. That was 2005 and I have been taking EZorb ever since.
I have referred EZorb to hundreds of people and most of them are very thankful. I believe in your product and want to sell it for profit.
III: From Alain D.
at feedback @ elixirindustry.com on
Tuesday, September 24, 2013 7:51 AM
I reordered Marvlix today as against all drugs. I have noticed a great gradual improvement on my lung disorder (doctor insist it is asthma but I have not been convinced. though).
At times my chest has been terribly congested and I had trouble catching my breath just walking. I had this trouble before -on and off - and had gotten over it...lately though this recurring problem was most severe and did not seem to go away but your product seems very effective and at this point I am most thankful!!
the Desk of EZorb Newsletter Editor:
newsletter is now read by over 70,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ elixirindustry.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public.
Research News: Intensive BP Control May Not Be A Good Idea for Diabetes Patients
Very intensive control of blood pressure (BP) in patients with Type 2 diabetes does not prevent cognitive decline and may even be counterproductive, suggest findings from the ACCORD MIND substudy.
The MIND (Memory in Diabetes) substudy tracked the cognition and total brain volume of a group of participants in ACCORD (Action to Control Cardiovascular Risk in Diabetes), which investigated the effects of intensive risk factor control in patients with diabetes.
The substudy previously showed that tight glycaemia control did not affect participants' cognitive outcomes, relative to standard control, and the latest analyses of two further studies nested within the MIND substudy show the same lack of benefit for treating systolic BP (SBP) to a target of 120 mmHg and for combination treatment of lipid levels.
A total of 1274 patients in the BP-lowering study undertook the Digit Symbol Substitution Test (DSST) at baseline and after 40 months of follow-up. The average DSST score declined slightly over this period, from 52.3 to 50.4 in patients treated to a target of 120 mmHg and from 52.3 to 50.7 in those treated to the standard target of 140 mmHg, with the difference between the groups nonsignificant.
And neither did the BP treatment target affect outcomes for the Stroop test, the Mini-Mental State Examination or the Rey Auditory Verbal Learning Test.
However, intensive BP control appeared to have an adverse effect on brain volume, report Jeff Williamson (Wake Forest School of Medicine, Winston-Salem, North Carolina, USA) and team in JAMA Internal Medicine.
Among 314 patients in the BP-lowering study who also underwent baseline and 40-month magnetic resonance imaging, total brain volume fell from a baseline of 921.5 cm3 to 902.6 cm3 in the intensive-treatment group and 907.0 cm3 in the standard-treatment group. The reductions from baseline, of 18.9 and 14.5 cm3, respectively, were significantly different.
In an accompanying commentary, Carole Dufouil (INSERM, Bordeaux, France) and Carol Brayne (University of Cambridge, UK) say: "Treatment effects are first seen on structure and then on function if the follow-up of participants is long enough."
Given that brain atrophy is closely tied to dementia, longer follow-up could therefore reveal adverse effects of intensive BP control on cognition.
"The potential for adverse outcomes with tight BP control suggests that, with greater knowledge about the effect of BP on dementia risk during the life course, enthusiastic control of BP later in life should be pursued with caution and based on existing evidence, not extrapolated benefits," they conclude.
Original research was published in JAMA Intern Med 2014; Advance online publication.
Asked Questions & Answers
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix.